Disclaimer

By clicking on 'Book An Appointment' you are agreeing to the disclaimer. Please read carefully.

SETU Sverige Foundation and this website does not provide any medical advice.

This initiative of SETU Sverige Foundation is for providing an online platform only, not any medical advice or guarantee of outcome from SETU Sverige Foundation. The advice is from the reputed MCI registered doctors; The initiative is for the persons currently residing only in India.

 

However, SETU Sverige Foundation is not responsible for errors or omissions in reporting or prescribing or explanation. No individuals, including those using this platform is encouraged to treat any serious medical symptoms. SETU Sverige Foundation gives no assurance or warranty regarding the accuracy, timeliness or applicability of the doctor’s advice.

SETU Sverige Foundation and this website does not provide medical advice. All of the material provided under this, if any, such as text, treatments, dosage, outcomes, charts, patients profiles, graphics, photographs, images, advice, messages, forums, postings, and any other material provided by the doctors are own their own will or discretion, SETU Sverige Foundation is not responsible for any of the above mentioned.

 

Reliance on this initiative provided by SETU Sverige Foundation, by persons appearing on the consultations at the invitations by SETU Sverige Foundation, or by any other means is solely at your own risk.

Any advice given and taken using this platform provided by SETU Sverige Foundation is at the doctor’s and patient’s discretion and is his or her sole responsibility.

  • This is a noble initiative by SETU Sverige Foundation to help millions of people who are suffering from COVID 19 and do not have access to health care facility.

  • The doctors will connect you  via ZOOM in accordance with the Telemedicine Practice Guideline, March, 2020 by Medical Council of India and Niti Aayog.

  • SETU Sverige Foundation is a connecting link between patients and doctors. In case any discrepancies arise, it has to be sorted out between medical practitioners and patients.

  • Registered medical practitioners (RMPs) using telemedicine shall uphold the same professional and ethical norms and standards as applicable to traditional in-person care, within the intrinsic limitations of telemedicine.

  • Principles of medical ethics, including professional norms for protecting patient privacy and confidentiality as per IMC Act shall be practiced by the RMPs.

  • Strict confidentiality will be maintained regarding identification, symptoms and treatment and COVID status of the patients. Basic co-morbidity data will be collected before teleconsultation to understand the diseases & patient better by the RMPs and to ease further follow up. 

  • Teleconsultations have been recommended for mild to moderately symptomatic cases. The doctors may refuse to entertain a patient if at any point of time they feel that the patient is severely symptomatic and needs hospital admission.

  • Telemedicine consultation should not be anonymous: both patient and the RMP need to know each other’s identity. During consultations doctors may ask for identification ID for the patient vis a vis RMP shall display the registration number accorded to him/her by the State Medical Council/MCI, on prescriptions, electronic communications and receipts etc. given to his/her patients.

  • Sometime RMPs can ask for certain tests/investigations which are relevant for the disease process. It’s the responsibility of the patients to get them done. Similarly RMPs may prescribe some medicines which have to be procured by the patients and their relatives. The doctors will never recommend any laboratory or medicine shops in particular.

  • Please do not insist on certain drugs with which the RMPs are not comfortable and list of prohibited drugs under Teleconsultation guidelines, 2020.

© 2020 by SETU SF. | Org. No. 802530-2145 | Created by SETU Sverige Foundation  |  Terms of Use  |   Privacy Policy | Photos Donated by Sarasij 

  • Facebook
  • LinkedIn
  • Twitter
  • Instagram
  • Facebook_Messenger-512
  • Facebook
  • Twitter
  • unnamed (1)
  • Instagram
  • LinkedIn